These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia. Andrew HG Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668 [TBL] [Abstract][Full Text] [Related]
5. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population. Cohen S; Khan A; Zheng Y; Chiles J Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398 [TBL] [Abstract][Full Text] [Related]
6. [Current data on neurologic sequelae caused by neuroleptics]. Krebs MO Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342 [TBL] [Abstract][Full Text] [Related]
7. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation. Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223 [TBL] [Abstract][Full Text] [Related]
12. Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design. Dixon L; Thaker G; Conley R; Ross D; Cascella N; Tamminga C Schizophr Res; 1993 Oct; 10(3):267-71. PubMed ID: 8260445 [TBL] [Abstract][Full Text] [Related]
13. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics]. Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594 [TBL] [Abstract][Full Text] [Related]
14. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. Soares-Weiser K; Rathbone J Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425 [TBL] [Abstract][Full Text] [Related]
15. Association of negative symptoms with tardive dyskinesia in schizophrenic patients. Chiu H; Lau J; Lam L; Shum P Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320 [TBL] [Abstract][Full Text] [Related]
16. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. McGrath JJ; Soares KV Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546 [TBL] [Abstract][Full Text] [Related]
17. Current cannabis use and tardive dyskinesia. Zaretsky A; Rector NA; Seeman MV; Fornazzari X Schizophr Res; 1993 Dec; 11(1):3-8. PubMed ID: 7905284 [TBL] [Abstract][Full Text] [Related]
18. Predictors of the course of tardive dyskinesia in patients receiving neuroleptics. Bergen J; Kitchin R; Berry G Biol Psychiatry; 1992 Oct; 32(7):580-94. PubMed ID: 1360260 [TBL] [Abstract][Full Text] [Related]